These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2656334)

  • 1. A review of combined hyperlipidaemia and its treatment with fenofibrate.
    Superko HR
    J Int Med Res; 1989; 17(2):99-112. PubMed ID: 2656334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia.
    Knopp RH; Brown WV; Dujovne CA; Farquhar JW; Feldman EB; Goldberg AC; Grundy SM; Lasser NL; Mellies MJ; Palmer RH
    Am J Med; 1987 Nov; 83(5B):50-9. PubMed ID: 3318454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy and safety of fenofibrate and lovastatin in patients with primary type IIa or IIb hyperlipidaemia.
    Gholami K; Tavakoli N; Maleki M; Shafiee A
    J Clin Pharm Ther; 1998 Jun; 23(3):213-21. PubMed ID: 9831973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential use of fenofibrate and other fibric acid derivatives in the clinic.
    Brown WV
    Am J Med; 1987 Nov; 83(5B):85-9. PubMed ID: 3688012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of clinical studies of fenofibrate in combination with currently approved lipid-lowering drugs.
    Brown WV
    Cardiology; 1989; 76 Suppl 1():45-51; discussion 52-4. PubMed ID: 2653623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypercholesterolaemia with fenofibrate: a review.
    Brown WV
    Curr Med Res Opin; 1989; 11(5):321-30. PubMed ID: 2649318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Micronized fenofibrate, decreased triglyceride levels, total cholesterol and LDL fractions in serum].
    Zaborska B; Kłoś J; Sikora-Frac M; Cybulska B; Ceremuzyński L
    Pol Arch Med Wewn; 2000 Jul; 104(1):371-5. PubMed ID: 11303327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
    Durrington PN; Tuomilehto J; Hamann A; Kallend D; Smith K
    Diabetes Res Clin Pract; 2004 May; 64(2):137-51. PubMed ID: 15063607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronized fenofibrate: a new fibric acid hypolipidemic agent.
    Guay DR
    Ann Pharmacother; 1999 Oct; 33(10):1083-103. PubMed ID: 10534222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease.
    Farnier M; Retterstøl K; Steinmetz A; Császár A
    Diab Vasc Dis Res; 2012 Jul; 9(3):205-15. PubMed ID: 22228773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
    Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
    Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on fenofibrate.
    Brown WV
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():31-40. PubMed ID: 3134383
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of European clinical experience with fenofibrate.
    Blane GF
    Cardiology; 1989; 76 Suppl 1():1-10; discussion 10-3. PubMed ID: 2653620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of fenofibrate or gemfibrozil on serum lipid profiles in Chinese patients with type IIb hyperlipidemia: a single-blind, randomized, and cross-over study.
    Jen SL; Chen JW; Lee WL; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Apr; 59(4):217-24. PubMed ID: 9216117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease].
    Kłosiewicz-Latoszek L; Respondek W; Białobrzeska-Paluszkiewicz J; Grzybowska B; Jakóbisiak-Ostasz B; Stolarska I
    Pol Merkur Lekarski; 2003 Jul; 15(85):42-6. PubMed ID: 14593958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined procetofene--nicotinic acid therapy in treatment of hypertriglyceridaemia.
    Rössner S; Olsson AG
    Atherosclerosis; 1980 Apr; 35(4):413-7. PubMed ID: 7378121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the effects of fenofibrate on lipoproteins, apoproteins, and bile saturation: US studies.
    Knopp RH
    Cardiology; 1989; 76 Suppl 1():14-22; discussion 29-32. PubMed ID: 2653621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action of fenofibrate in hypercholesterolemic children. 18-month follow-up].
    Chicaud P; Demange J; Drouin P; Debry G
    Presse Med; 1984 Feb; 13(7):417-9. PubMed ID: 6230609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy.
    Farnier M; Ducobu J; Bryniarski L
    Curr Med Res Opin; 2011 Nov; 27(11):2165-73. PubMed ID: 21973199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.